These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 18997483)

  • 21. Circulating resistin levels are lower in hypothyroid women but independent from thyroid hormones concentrations.
    Owecki M; El Ali Z; Waśko R; Nikisch E; Sowiński J
    Neuro Endocrinol Lett; 2008 Feb; 29(1):131-6. PubMed ID: 18283268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Graves' ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: prevalence, natural history, and thyrotropin receptor antibody levels.
    Khoo DH; Eng PH; Ho SC; Tai ES; Morgenthaler NG; Seah LL; Fong KS; Chee SP; Choo CT; Aw SE
    Thyroid; 2000 Dec; 10(12):1093-100. PubMed ID: 11201855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves' orbitopathy.
    Nicolì F; Lanzolla G; Mantuano M; Ionni I; Mazzi B; Leo M; Sframeli A; Posarelli C; Maglionico MN; Figus M; Nardi M; Marcocci C; Marinò M
    J Endocrinol Invest; 2021 Mar; 44(3):581-585. PubMed ID: 32648002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Down-regulated resistin level in consequence of decreased neutrophil counts in untreated Grave's disease.
    Peng Y; Qi Y; Huang F; Chen X; Zhou Y; Ye L; Wang W; Ning G; Wang S
    Oncotarget; 2016 Nov; 7(48):78680-78687. PubMed ID: 27637079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism.
    Gunji K; De Bellis A; Li AW; Yamada M; Kubota S; Ackrell B; Wengrowicz S; Bellastella A; Bizzarro A; Sinisi A; Wall JR
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1641-7. PubMed ID: 10770210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization and clinical relevance of circulating CD4+CD28- T cells in Graves' disease.
    Wang F; Chen L; Shen Q; Liu T; Jiang L; Gu X; Chen L; Sun J; Liu C
    Immunol Lett; 2015 May; 165(1):47-51. PubMed ID: 25839128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-21 is associated with disease activity in patients with Graves' disease.
    Zhang J; Zeng H; Ren M; Yan H; Xu M; Feng Z; Liang W; Yang C; Cheng H; Ding H; Yan L
    Endocrine; 2014 Aug; 46(3):539-48. PubMed ID: 24287789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High serum osteoprotegerin levels in patients with hyperthyroidism: effect of medical treatment.
    Amato G; Mazziotti G; Sorvillo F; Piscopo M; Lalli E; Biondi B; Iorio S; Molinari A; Giustina A; Carella C
    Bone; 2004 Sep; 35(3):785-91. PubMed ID: 15336617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevation of serum adiponectin levels in Basedow disease.
    Saito T; Kawano T; Saito T; Ikoma A; Namai K; Tamemoto H; Kawakami M; Ishikawa SE
    Metabolism; 2005 Nov; 54(11):1461-6. PubMed ID: 16253634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in adipocyte hormones leptin, resistin, and adiponectin in thyroid dysfunction.
    Yaturu S; Prado S; Grimes SR
    J Cell Biochem; 2004 Oct; 93(3):491-6. PubMed ID: 15372626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical significance of thyroglobulin antibodies and thyroid peroxidase antibodies in Graves' disease: a cross-sectional study.
    Katahira M; Tsunekawa T; Mizoguchi A; Yamaguchi M; Tsuru K; Takashima H; Terada R
    Hormones (Athens); 2023 Jun; 22(2):253-261. PubMed ID: 36811756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody-dependent cell-mediated cytotoxicity against orbital target cells in thyroid-associated ophthalmopathy and related disorders; close relationship between serum cytotoxic antibodies and parameters of eye muscle dysfunction.
    Barsouk A; Peele KA; Kiljanski J; Stolarski C; Nebes V; Kennerdell JS; Volpe R; Wall JR
    J Endocrinol Invest; 1996 Jun; 19(6):334-41. PubMed ID: 8844451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of thyrotropin-releasing hormone on serum thyroid hormones: a study in the patients with untreated and treated Graves' disease and subacute thyroiditis.
    Sato A; Yamada T; Aizawa T; Ichikawa K; Komiya I; Takasu N; Takemura Y
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2173-7. PubMed ID: 7608274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Triiodothyronine-predominant Graves' disease in childhood: detection and therapeutic implications.
    Harvengt J; Boizeau P; Chevenne D; Zenaty D; Paulsen A; Simon D; Guilmin Crepon S; Alberti C; Carel JC; Léger J
    Eur J Endocrinol; 2015 Jun; 172(6):715-23. PubMed ID: 25766047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationships between adiponectin, sex hormone binding globulin and insulin resistance in hyperthyroid Graves' disease women.
    Siemińska L; Foltyn W; Głogowska-Szeląg J; Kajdaniuk D; Marek B; Nowak M; Walczak K; Kos-Kudła B
    Endokrynol Pol; 2013; 64(1):26-9. PubMed ID: 23450444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum thyrotropin receptor antibodies concentrations in patients with Graves' disease before, at the end of methimazole treatment, and after drug withdrawal: evidence that the activity of thyrotropin receptor antibody and/or thyroid response modify during the observation period.
    Carella C; Mazziotti G; Sorvillo F; Piscopo M; Cioffi M; Pilla P; Nersita R; Iorio S; Amato G; Braverman LE; Roti E
    Thyroid; 2006 Mar; 16(3):295-302. PubMed ID: 16571093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum immunoglobulin G4 levels and Graves' disease phenotype.
    Martin CS; Sirbu AE; Betivoiu MA; Florea S; Barbu CG; Fica SV
    Endocrine; 2017 Feb; 55(2):478-484. PubMed ID: 27819113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Irisin and Myostatin Levels in Patients with Graves' Disease.
    Yalcin MM; Akturk M; Tohma Y; Cerit ET; Altinova AE; Arslan E; Yetkin I; Toruner FB
    Arch Med Res; 2016 Aug; 47(6):471-475. PubMed ID: 27986127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Association of Thyroid Stimulating Hormone Receptor Antibody Levels with Disease Severity in the Chronic Inactive Stage of Graves' Orbitopathy.
    Woo YJ; Jang SY; Lim TH; Yoon JS
    Korean J Ophthalmol; 2015 Aug; 29(4):213-9. PubMed ID: 26240504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of various contraceptives on laboratory parameters in diagnosis of thyroid gland function with special reference to the free hormones FT4 and FT3].
    Sorger D; Schenk S; Schneider G
    Z Gesamte Inn Med; 1992 Feb; 47(2):58-64. PubMed ID: 1585690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.